Other miliary tuberculosis
ICD-10 A19.8 is a billable code used to indicate a diagnosis of other miliary tuberculosis.
Miliary tuberculosis is a disseminated form of tuberculosis (TB) characterized by the presence of numerous small lesions (millet seed-sized) throughout the body, particularly in the lungs. It occurs when Mycobacterium tuberculosis spreads through the bloodstream, leading to a systemic infection. Patients may present with nonspecific symptoms such as fever, weight loss, night sweats, and respiratory distress. Diagnosis typically involves a combination of clinical evaluation, imaging studies like chest X-rays or CT scans, and microbiological tests including sputum cultures or biopsies. Treatment usually consists of a multi-drug regimen, often including isoniazid, rifampicin, pyrazinamide, and ethambutol, for an extended duration. Monitoring for drug resistance is crucial, as resistant strains can complicate treatment and increase morbidity. Public health implications are significant, as miliary TB can be highly contagious, necessitating contact tracing and isolation procedures to prevent outbreaks. The condition requires careful management to ensure adherence to treatment and to monitor for potential complications, such as respiratory failure or disseminated infection.
Detailed patient history, diagnostic test results, treatment plans, and follow-up care.
Patients presenting with systemic symptoms, confirmed TB exposure, or abnormal imaging findings.
Ensure documentation reflects the severity of the disease and any complications.
Pulmonary function tests, imaging studies, and treatment response evaluations.
Patients with respiratory symptoms and confirmed or suspected miliary TB.
Document any respiratory complications and the need for isolation.
Used for screening patients at risk for TB.
Document the reason for testing and results.
Infectious disease specialists should ensure proper follow-up for positive results.
Common symptoms include fever, night sweats, weight loss, fatigue, and respiratory distress. Patients may also experience cough and chest pain.
Diagnosis typically involves a combination of clinical evaluation, imaging studies (like chest X-rays or CT scans), and microbiological tests such as sputum cultures or biopsies.
Treatment usually involves a multi-drug regimen including isoniazid, rifampicin, pyrazinamide, and ethambutol for an extended duration, often 6-12 months.
Miliary TB can be highly contagious, necessitating contact tracing and isolation procedures to prevent outbreaks. Public health reporting is crucial for managing TB cases.
